Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › KIR3DL2 binding agents

KIR3DL2 binding agents

US Patent 10577419 · Granted Mar 3, 2020

Estimated economic value: $520,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of T cell lymphoma2025
NKp46 binding agents2025
NKp46 binding agents2025
Multispecific NK engager protein2025
Multispecific NK engager protein2025
Humanized antibodies with increased stability2025
Nucleic acids encoding and methods of producing proteins comprising antibody cha2025
Nucleic acids encoding and methods of producing proteins comprising antibody cha2025
Nucleic acids encoding and methods of producing proteins comprising antibody cha2025
Natural killer (NK) cell engagers binding to NKp46 and BCMA variants with Fc-eng2025
Compound that specifically binds to KIR3DL2 for use in the treatment of peripher2024
Treatment regimens using anti-NKG2A antibodies2024